These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 6876431)

  • 21. A multifactorial analysis of different biological and clinical parameters in breast cancer.
    Toma S; Coialbu T; Bonassi S; Nicolò G; Rosso R
    Anticancer Res; 1987; 7(3 Pt B):401-7. PubMed ID: 3631893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of steroid receptors with histopathologic characteristics in breast carcinoma.
    Bhatavdekar JM; Trivedi SN; Shah NG; Karelia NH; Patel DD; Giri DD; Patel TB
    Neoplasma; 1988; 35(4):413-23. PubMed ID: 3185838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients.
    Blanco G; Alavaikko M; Ojala A; Collan Y; Heikkinen M; Hietanen T; Aine R; Taskinen PJ
    Anticancer Res; 1984; 4(6):383-9. PubMed ID: 6097159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of steroid receptors in synchronous tissues with survival in breast cancer patients.
    Bhatavdekar JM; Patel DD; Karelia NH; Suthar TP; Shah NG; Vora HH; Ghosh N; Nadkarni SP; Balar DB
    Neoplasma; 1993; 40(3):177-80. PubMed ID: 8350965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steroid hormone receptors and response to high-dose medroxyprogesterone acetate in advanced breast cancer.
    Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K
    Anticancer Res; 1988; 8(4):647-51. PubMed ID: 2972248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction.
    Iwao K; Miyoshi Y; Egawa C; Ikeda N; Tsukamoto F; Noguchi S
    Cancer; 2000 Oct; 89(8):1732-8. PubMed ID: 11042568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and experimental aspects of hormone receptors in breast carcinoma patients.
    Spona J; Kolb R; Reiner G; Jakesz R; Moser K; Rainer H
    Cancer Detect Prev; 1983; 6(1-2):227-34. PubMed ID: 6883382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical staining of estrogen and progesterone receptors: aspects for evaluating positivity and defining the cutpoints.
    Jalava P; Kuopio T; Huovinen R; Laine J; Collan Y
    Anticancer Res; 2005; 25(3c):2535-42. PubMed ID: 16080489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of intra-tumoral estradiol level in breast cancer patients.
    Miyoshi Y; Akazawa K; Kamigaki S; Ueda S; Yanagisawa T; Inoue T; Yamamura J; Taguchi T; Tamaki Y; Noguchi S
    Cancer Lett; 2004 Dec; 216(1):115-21. PubMed ID: 15500955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients.
    Aryandono T; Harijadi ; Ghozali A
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():600-6. PubMed ID: 10895217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Receptor status and ovarian function in carcinoma of the breast].
    Giuffrida D; La Porta GA; Sicurella C; La Rosa GL; Milazzo G; Foti E; Marchese V; Lanza C; Vigneri R; Belfiore A
    G Ital Oncol; 1989; 9(2-3):73-6. PubMed ID: 2767731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Menopausal status and cut off levels of steroid receptor ligand binding assays in breast cancer.
    Norgren A; Forsberg AH; Lindgren A; Sällström JF
    Anticancer Res; 1989; 9(1):173-6. PubMed ID: 2495752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone receptors and Japanese breast cancer.
    Matsumoto K; Kitamura Y; Sugano H
    Acta Pathol Jpn; 1982; 32 Suppl 1():145-54. PubMed ID: 6764994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new look at the prognostic value of the estrogen, progesterone and epidermal growth factor receptors in breast cancer tissue.
    Skasko E; Paszko Z; Mazur S
    Neoplasma; 2005; 52(1):10-7. PubMed ID: 15739020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. International comparisons concerning breast cancer and steroid receptors.
    Matsumoto K; Sakamoto G; Nomura Y
    Anticancer Res; 1986; 6(4):621-4. PubMed ID: 3752942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women.
    Balleine RL; Earl MJ; Greenberg ML; Clarke CL
    Br J Cancer; 1999 Mar; 79(9-10):1564-71. PubMed ID: 10188907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen and progesterone receptors status in Thai female breast cancer patients: an analysis of 399 cases at King Chulalongkorn Memorial Hospital.
    Lertsanguansinchai P; Chottetanaprasith T; Chatamra K; Sampatanukul P; Wannakrairot P; Rojpornpradit P; Shotelersuk K; Lertbutsayanukul C; Boonjunwetwat D; Vajragupta L
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S193-202. PubMed ID: 12188412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival of women with node negative breast cancer in the Auckland region.
    Lethaby AE; Mason BH; Harvey VJ; Holdaway IM
    N Z Med J; 1996 Sep; 109(1029):330-3. PubMed ID: 8862351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of estrogen, progesterone and prolactin receptors in human breast cancer.
    Calandra RS; Charreau EH; Royer de Giaroli M; Baldi A
    Prog Clin Biol Res; 1984; 142():97-108. PubMed ID: 6709661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.